The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1329
ISSUE1329
January 11, 2010
Telavancin (Vibativ) for Gram-Positive Skin Infections
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Telavancin (Vibativ) for Gram-Positive Skin Infections
January 11, 2010 (Issue: 1329)
Telavancin (Vibativ - Astellas and Theravance), a lipoglycopeptide derivative of vancomycin (Vancocin, and others), has received FDA approval for treatment of complicated skin and skin structure infections caused by susceptible gram-positive bacteria...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.